NovaBay Pharmaceuticals (NYSE:NBY) Reports Revenues Of $1.9 Million In Q4 2020:...
NovaBay Pharmaceuticals (NYSE:NBY) reported a growth of 10% YoY in Q4 2020 revenues to $1.9 million. Its full-year revenues are $9.9 million (up 51%...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Dare Biosciences Inc. (NASDAQ:DARE) Reports Positive DARE-BV1 Study Results In Bacterial...
Dare Biosciences Inc. (NASDAQ:DARE) has announced encouraging top-line DARE-BVFREE Third Phase double-blinded, randomized, placebo-controlled clinical study results. The study evaluated the company's DARE-BV1 in...
MAKE IT MODERN
LATEST REVIEWS
The Coming Boost to Sports Media Stocks? (NKE, CHDN, BTDG, DKNG)
The Sports Media market is one of the most dynamic and chronically successful in the US economy and capital markets. But it has also...
MAKE IT MODERN
PERFORMANCE TRAINING
Phantom Pharmaceuticals Inc. (NASDAQ: PHAT) Announce Positive Results of Study Evaluating Vonoprazan in NERD Treatment
Phantom Pharmaceuticals Inc. (NASDAQ: PHAT) has announced positive findings from PHALCON-NERD, a second phase trial assessing three vonoprazan dose levels (40mg, 20mg, and 10mg)...
Adverum Biotechnologies Inc. (NASDAQ:ADVM) And Trillium Therapeutics Inc. (NASDAQ:TRIL) Make Leadership Appointment
Adverum Biotechnologies Inc. (NASDAQ:ADVM) has announced the appointment of Christopher J Morrison as the company's VP process development, and he will report Angela Thedinga,...
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan Drug Designation RGLS8429
Regulus Therapeutics Inc (NASDAQ: RGLS) is pleased after the U.S. Food and Drug Administration (FDA) made its determination and approved its orphan drug designation...
Cerecor Inc. (NASDAQ:CERC) Receives IND Approval From The FDA For CERC-002 In Treatment of...
Cerecor Inc. (NASDAQ:CERC) has announced that the FDA has given it a clearance to go on with its proof-of-concept clinical study of the Anti-LIGHT...
Gentech Holdings Inc (OTCMKTS:GTEH) Continues to Build Momentum with Wheelpay Deal
GenTech Holdings Inc (OTCMKTS:GTEH) could be an increasingly interesting OTC name following its acquisition of Sinfit Nutrition in June. Sinfit, it should be noted,...
MAKE IT MODERN
